The possibility that SC-43 may also target fibroblasts by inhibiting their STAT3 signaling is of great importance, since the anti-IPF medication nintedanib has been reported to suppress STAT3 and induce senolytic death in bleomycin-instilled mouse fibroblasts [66]. Here, STAT3 is linked to idiopathic pulmonary fibrosis.